שם החברה: Glycominds Ltd.

שנת ייסוד: 1999

מספר עובדים:

סקטור: Life sciences

תת סקטור: Biotechnology

פרופיל חברה

Glycominds is pioneering the application of glycan markers to clinical practice in order to significantly improve the quality of treatment decisions for patients with autoimmune diseases. We provide superior blood tests based on serological markers for Inflammatory Bowel Disease (IBDX) and Multiple Sclerosis (gMS). Our pipeline includes tests for other autoimmn! ue diseases, which are among the most recognized poorly understood illnesses, where we found the largest unmet need for esoteric tests. Leveraging our proprietary GlycoChip(R) technology, we are rapidly discovering and validating novel markers for autoimmune diseases, keeping a continuous pipeline of high value products.